Rhythm Biosciences LimitedASX: RHY

Genetype Commercial Integration Completion

· Issued by Rhythm Biosciences Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Rhythm Biosciences Limited has announced the completion of the geneType commercial capability integration, which includes the restoration of essential commercial processes and partnerships. The integration allows Rhythm to offer the complete geneType product portfolio and is expected to enhance commercial opportunities for both the ColoSTAT and geneType platforms. Key personnel have been transferred to support the geneType product portfolio, and critical partnerships have been re-established to facilitate service delivery.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Rhythm Biosciences Limited on 6ix

Earlier from Rhythm Biosciences

Later from Rhythm Biosciences

All Rhythm Biosciences news releases